PeptideDB

Visilizumab

CAS: 219716-33-3 F: W:

Visilizumab (Anti-Human CD3E Recombinant Antibody) is a humanized low-Fc receptor binding anti-CD3 monoclonal IgG2 antib
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity Visilizumab (Anti-Human CD3E Recombinant Antibody) is a humanized low-Fc receptor binding anti-CD3 monoclonal IgG2 antibody. Visilizumab can be used for ulcerative colitis and Crohn's disease research[1].
Invitro Visilizumab 诱导固有层 T 细胞的剂量和时间依赖性细胞凋亡。Visilizumab 诱导固有层 T 细胞凋亡依赖于半胱天冬酶 3 和 8,而不是半胱天冬酶 9 的激活,并且不涉及 Fas/FasL 通路[1]。 Apoptosis Analysis[1] Cell Line:
Name Visilizumab
CAS 219716-33-3
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.